Wnt signaling in cancer

Cited by (1,002)

Items 701–800 of 1,002

1. Ras and Wnt Interaction Contribute in Prostate Cancer Bone Metastasis
   Shian‐Ren Lin, Ntlotlang Mokgautsi, Yen‐Nien Liu · 2020 · Molecules
2. Molecular Therapeutics of Pancreatic Ductal Adenocarcinoma: Targeted Pathways and the Role of Cancer Stem Cells
   Andrei-Florian Stoica, Chao‐Hui Chang, Siim Pauklin · 2020 · Trends in Pharmacological Sciences
3. Emerging Trends in Neuroblastoma Diagnosis, Therapeutics, and Research
   Rishabh Sharma, Jaya Yadav, Sajad Ahmad Bhat, Abdugani Musayev, Syrsulu Myrzagulova, Deepika Sharma, Nipun Padha, Manju Saini, Hardeep Singh Tuli, Tejveer Singh · 2025 · Molecular Neurobiology
4. Reciprocal Reprogramming of Cancer Cells and Associated Mesenchymal Stem Cells in Gastric Cancer
   Yeela Shamai, Dalia Cohn-Alperovich, Zohar Yakhini B, Karl L. Skorecki, Maty Tzukerman · 2018 · Stem Cells
5. Promotion of ovarian cancer cell invasion, migration and colony formation by the miR‑21/Wnt/CD44v6 pathway
   Yanqing Wang, Xiao Yang, Mengqin Yuan, Shu Xian, Li Zhang, Dongyong Yang, Yanxiang Cheng · 2019 · Oncology Reports
6. Interplay Between Ion Channels and the Wnt/β-Catenin Signaling Pathway in Cancers
   Raphaël Rapetti‐Mauss, Camille Berenguier, Benoit Allegrini, Olivier Soriani · 2020 · Frontiers in Pharmacology
7. RX-5902, a novel β-catenin modulator, potentiates the efficacy of immune checkpoint inhibitors in preclinical models of triple-negative breast Cancer
   John J. Tentler, Julie Lang, Anna Capasso, Deog Joong Kim, Ely Benaim, Young Bok Lee, Andrew Eisen, Stacey M. Bagby, Sarah J. Hartman, Betelehem W. Yacob et al. · 2020 · BMC Cancer
8. Striking Association of Lymphoid Enhancing Factor (LEF1) Overexpression and DUSP22 Rearrangements in Anaplastic Large Cell Lymphoma
   Aishwarya Ravindran, Andrew L. Feldman, Rhett P. Ketterling, Surendra Dasari, Karen L. Rech, Ellen Darcy McPhail, Paul J. Kurtin, Min Shi · 2020 · The American Journal of Surgical Pathology
9. Risk of lung cancer and renin–angiotensin blockade: a concise review
   Tobias Rachow, Helmut Schiffl, Susanne M. Lang · 2020 · Journal of Cancer Research and Clinical Oncology
10. Comparative Analysis of Genetic Alterations, HPV-Status, and PD-L1 Expression in Neuroendocrine Carcinomas of the Cervix
    Daisuke Takayanagi, Sou Hirose, Ikumi Kuno, Yuka Asami, Naoya Murakami, Maiko Matsuda, Yoko Shimada, Kuniko Sunami, Masaaki Komatsu, Ryuji Hamamoto et al. · 2021 · Cancers
11. CRISPR screens identify a novel combination treatment targeting BCL-XL and WNT signaling for KRAS/BRAF-mutated colorectal cancers
    Hae Rim Jung, Yumi Oh, Deukchae Na, Seoyeon Min, Jinjoo Kang, Dongjun Jang, Seungjae Shin, Ji‐Won Kim, Sang Eun Lee, Eui Man Jeong et al. · 2021 · Oncogene
12. The SIX Family of Transcription Factors: Common Themes Integrating Developmental and Cancer Biology
    Logan Meurer, Leonard Ferdman, Beau Belcher, Troy Camarata · 2021 · Frontiers in Cell and Developmental Biology
13. MICAL1 inhibits colorectal cancer cell migration and proliferation by regulating the EGR1/β-catenin signaling pathway
    Huanyu Gu, Yi Li, Cui Xiu-ping, Huiru Cao, Zhijuan Hou, Yunhe Ti, Da-Hua Liu, Jing Gao, Yu Wang, Pushuai Wen · 2021 · Biochemical Pharmacology
14. SIK2 maintains breast cancer stemness by phosphorylating LRP6 and activating Wnt/β-catenin signaling
    Zhuoxian Rong, Lu Zhang, Zhi Li, Zhi Qiang Xiao, Yumei Duan, Xinxin Ren, Yuyuan Zi, Jie Gao, Yun Mu, Yidi Guan et al. · 2022 · Oncogene
15. Targeting Wnt/β-Catenin Pathways in Primary Liver Tumours: From Microenvironment Signaling to Therapeutic Agents
    Federico Selvaggi, Teresa Catalano, Roberto Cotellese, Gitana María Aceto · 2022 · Cancers
16. Superresolution microscopy localizes endogenous Dvl2 to Wnt signaling-responsive biomolecular condensates
    Antonia Schubert, Oksana Voloshanenko, Franziska Ragaller, Philipp Gmach, Dominique Kranz, Christian Scheeder, Thilo Miersch, Matthias Schulz, Lorenz H. P. Trümper, Claudia Rebecca Binder et al. · 2022 · Proceedings of the National Academy of Sciences
17. Multiomics characterization implicates PTK7 in ovarian cancer EMT and cell plasticity and offers strategies for therapeutic intervention
    Juuli Raivola, Alice Dini, Hanna Karvonen, Emilia Piki, Kari Salokas, Wilhelmiina Niininen, Laura Kaleva, Kaiyang Zhang, Mariliina Arjama, Greta Gudoitytė et al. · 2022 · Cell Death and Disease
18. Inhibition of Wnt Signaling in Colon Cancer Cells via an Oral Drug that Facilitates TNIK Degradation
    Kun Zhou, Jae Eun Cheong, Subrahmanian Tarakkad Krishnaji, Aram Ghalali, Haojie Fu, Lufei Sui, Catherine Alix‐Panabières, Laure Cayrefourcq, Diane Renee Bielenberg, Lijun Sun et al. · 2022 · Molecular Cancer Therapeutics
19. Genetic dysregulation of immunologic and oncogenic signaling pathways associated with tumor-intrinsic immune resistance: a molecular basis for combination targeted therapy-immunotherapy for cancer
    Kristian Michael Hargadon · 2023 · Cellular and Molecular Life Sciences
20. Induction of Cancer Cell Death by Apigenin: A Review on Different Cell Death Pathways
    Peyman Amini, Reza Moazamiyanfar, Mohammad Sedigh Dakkali, Emad Jafarzadeh, Maryam Ganjizadeh, Nima Rastegar‐Pouyani, Kave Moloudi, Ehsan Khodamoradi, Shahram Taeb, Masoud Najafi · 2023 · Mini-Reviews in Medicinal Chemistry
21. Genetic polymorphisms of Wnt/β-catenin pathway genes are associated with the efficacy and toxicities of radiotherapy in patients with nasopharyngeal carcinoma
    Jingjing Yu, Yu‐Ling Huang, Lijuan Liu, Jing Wang, Ji‐Ye Yin, Lihua Huang, Shaojun Chen, Jingao Li, Hong Yuan, Guoping Yang et al. · 2016 · Oncotarget
22. Deregulation of Frizzled Receptors in Hepatocellular Carcinoma
    Kristy Kwan‐Shuen Chan, Regina Cheuk‐Lam Lo · 2018 · International Journal of Molecular Sciences
23. A β1-tubulin–based megakaryocyte maturation reporter system identifies novel drugs that promote platelet production
    Hideya Seo, Si Jing Chen, Kazuya Hashimoto, Hiroshi Endo, Yohei Nishi, Akira Ohta, Takuya Yamamoto, Akitsu Hotta, Akira Sawaguchi, Hideki Hayashi et al. · 2018 · Blood Advances
24. Role of cellular reprogramming and epigenetic dysregulation in acquired chemoresistance in breast cancer
    Logeswari Ponnusamy, Prathap Kumar S. Mahalingaiah, Yu-Wei Chang, Kamaleshwar P. Singh · 2019 · Cancer Drug Resistance
25. Targeting the Versatile Wnt/β-Catenin Pathway in Cancer Biology and Therapeutics: From Concept to Actionable Strategy
    K. Dzobo, N. Thomford, D. Senthebane · 2019 · Omics
26. The Role of Resveratrol in Cancer Management: From Monotherapy to Combination Regimens
    Eduarda Ribeiro, Nuno Vale · 2024 · Targets
27. De novo supraparticle construction by a self-assembled Janus cyclopeptide to tame hydrophilic microRNA and hydrophobic molecule for anti-tumor cocktail therapy and augmented immunity
    Junjun She, Yaguang Li, Siqi Yan, Yuwei Yan, Dan Liu, Shichao Li, Yi Guo, Yumeng Xue, Yu Yao, Jin Yan et al. · 2020 · Chemical Engineering Journal
28. Discovery of Novel Tankyrase Inhibitors through Molecular Docking-Based Virtual Screening and Molecular Dynamics Simulation Studies
    Vladimir P. Berishvili, Alexander N. Kuimov, Andrew E. Voronkov, Eugene V. Radchenko, Pradeep Kumar, Yahya Essop Choonara, Viness Pillay, Ähmed Kamal, Vladimir A. Palyulin · 2020 · Molecules
29. Effect of casein kinase 1α inhibition on autophagy flux and the AKT/phospho-β-catenin (S552) axis in HCT116, a RAS-mutated colorectal cancer cell line
    Hamid Behrouj, Atefeh Seghatoleslam, Pooneh Mokarram, Saeid Ghavami · 2021 · Canadian Journal of Physiology and Pharmacology
30. Non-Coding RNAs Set a New Phenotypic Frontier in Prostate Cancer Metastasis and Resistance
    Joshua Altschuler, Jennifer A. Stockert, Natasha Kyprianou · 2021 · International Journal of Molecular Sciences
31. Targeting of Deregulated Wnt/β-Catenin Signaling by PRI-724 and LGK974 Inhibitors in Germ Cell Tumor Cell Lines
    Silvia Schmidtova, Katarína Kaľavská, Veronika Lišková, Jana Plavá, Svetlana Miklikova, Lucia Kučerová, Miroslava Matúšková, Lucia Rojikova, Zuzana Čierna, Adriana L. Rogozea et al. · 2021 · International Journal of Molecular Sciences
32. SMAD4 is critical in suppression of BRAF-V600E serrated tumorigenesis
    Kevin Tong, Om A. Kothari, Katherine S. Haro, Anshuman Panda, Manisha Bandari, Jillian N. Carrick, Joseph Hur, Lanjing Zhang, Chang S. Chan, Jinchuan Xing et al. · 2021 · Oncogene
33. UBE2T promotes β‐catenin nuclear translocation in hepatocellular carcinoma through MAPK/ERK‐dependent activation
    Elisavet Lioulia, Panagiotis Mokos, Emmanuel Panteris, Dimitra Dafou · 2021 · Molecular Oncology
34. The Organizer and Its Signaling in Embryonic Development
    Vijay Kumar, Soochul Park, Unjoo Lee, Jaebong Kim · 2021 · Journal of Developmental Biology
35. PINTology : A short history of the lncRNA LINC‐PINT in different diseases
    Ihtisham Bukhari, Muhammad Riaz Khan, Mohammed Amir Husain, Rick Francis Thorne, Yong Yu, Bingyong Zhang, Pengyuan Zheng, Yang Mi · 2022 · Wiley Interdisciplinary Reviews - RNA
36. Translocation of Helicobacter hepaticus synergizes with myeloid-derived suppressor cells and contributes to breast carcinogenesis
    Huan Deng, Sureshkumar Muthupalani, Susan E. Erdman, Haibo Liu, Zhengchuan Niu, Timothy Cragin Wang, James G. Fox · 2022 · OncoImmunology
37. PROTACs in gastrointestinal cancers
    Yu Chen, Qingfan Yang, Jinrun Xu, Liyao Tang, Yan Zhang, Fukuan Du, Yueshui Zhao, Xu Wu, Mingxing Li, Jing Shen et al. · 2022 · Molecular Therapy — Oncolytics
38. Macrophages and Wnts in Tissue Injury and Repair
    Min Hee Park, Eun D. Lee, Wook‐Jin Chae · 2022 · Cells
39. Phosphoproteomic analysis of metformin signaling in colorectal cancer cells elucidates mechanism of action and potential therapeutic opportunities
    Barbora Šalovská, Erli Gao, Sophia Müller‐Dott, Wenxue Li, Carlos Chacon Cordon, Shisheng Wang, Aurélien J. F. Dugourd, George Rosenberger, Julio Sáez-Rodríguez, Yansheng Liu · 2023 · Clinical and Translational Medicine
40. Ubiquitin-specific peptidase 5 facilitates cancer stem cell-like properties in lung cancer by deubiquitinating β-catenin
    Chia-Hao Tung, Jiaen Wu, Meng‐Fan Huang, Wen-Lung Wang, Yi-Ying Wu, Yao-Tsung Tsai, Xiu-Rui Hsu, Sheng‐Hsiang Lin, Yuh‐Ling Chen, Tse-Ming Hong · 2023 · Cancer Cell International
41. Genes involved in the WNT and vesicular trafficking pathways are associated with melanoma predisposition
    Maider Ibarrola‐Villava, Rajiv Kumar, Eduardo Nagore, M. Benfodda, Mickaël Guedj, Steven Gazal, Hui‐Han Hu, Jian Guan, P. Sivaramakishna Rachkonda, V. Descamps et al. · 2014 · International Journal of Cancer
42. Distinct DNA Methylation Profiles in Ovarian Tumors: Opportunities for Novel Biomarkers
    Lorena Losi, Sergio Fonda, Sara Saponaro, Sonia Tassadit Chelbi, Cesare Lancellotti, Gaia Gozzi, Loredana Alberti, Luca Fabbiani, Laura Botticelli, Jean Benhattar · 2018 · International Journal of Molecular Sciences
43. Pygo2 Regulates Adiposity and Glucose Homeostasis via β-Catenin–Axin2–GSK3β Signaling Pathway
    Yuanyuan Xie, Chunli Mo, Yihuang Cai, Wenjie Wang, Xin-Xin Hong, Kunkun Zhang, Qingfeng Liu, Yun-Jia Liu, Jing-Jing Hong, Ting He et al. · 2018 · Diabetes
44. TGF β‐1 and WNT Signaling Pathways Collaboration Associated with Cochlear Implantation Trauma‐Induced Fibrosis
    Esperanza Bas, Mir R. Anwar, Thomas R. Van De Water · 2019 · The Anatomical Record
45. Oncogenic Mutations in Armadillo Repeats 5 and 6 of β-Catenin Reduce Binding to APC, Increasing Signaling and Transcription of Target Genes
    Pengyu Liu, Bin-yong Liang, Menggang Liu, Joyce H.G. Lebbink, Shan Li, Manning Qian, Marla Lavrijsen, Maikel Petrus Peppelenbosch, Xin Chen, Ron Smits · 2019 · Gastroenterology
46. The multiple ways Wnt signaling contributes to acute leukemia pathogenesis
    Sheila Coelho Soares‐Lima, Maria S. Pombo‐de‐Oliveira, Flávia Raquel Gonçalves Carneiro · 2020 · Journal of Leukocyte Biology
47. Fusobacterium nucleatum modulates the Wnt/β-catenin pathway in colorectal cancer development
    Tanushree Mondal, Deepanjan Chattopadhyay, Paromita Saha Mondal, Sanjib Das, Amalesh Mondal, Abhishek Das, Subhasree Samanta, Tanima Saha · 2025 · International Journal of Biological Macromolecules
48. Different behaviour of DVL 1, DVL 2, DVL 3 in astrocytoma malignancy grades and their association to TCF 1 and LEF 1 upregulation
    Anja Kafka, Mateja Bačić, Davor Tomas, Kamelija Žarković, Anja Bukovac, Niko Njirić, Goran Mrak, Željka Krsnik, Nives Pećina‐Šlaus · 2018 · Journal of Cellular and Molecular Medicine
49. Loss of MADD expression inhibits cellular growth and metastasis in anaplastic thyroid cancer
    Shikha Saini, Lakshmi Sripada, Kiara A. Tulla, Prabhakaran Kumar, Fei Yue, Nicholas M. Kunda, Ajay V. Maker, Bellur S. Prabhakar · 2019 · Cell Death and Disease
50. Evaluation of associations between genetically predicted circulating protein biomarkers and breast cancer risk
    Xiang Shu, Jiandong Bao, Lang Wu, Jirong Long, Xiao‐Ou Shu, Xingyi Guo, Yaohua Yang, Kyriaki Michailidou, Manjeet K. Bolla, Qin Wang et al. · 2019 · International Journal of Cancer
51. Wnt-β-catenin Signaling Pathway, the Achilles' Heels of Cancer Multidrug Resistance
    Morteza Ghandadi, Reza Valadan, Hamidreza Mohammadi, Javad Akhtari, Shabanali Khodashenas, Sorour Ashari · 2019 · Current Pharmaceutical Design
52. MCM6 indicates adverse tumor features and poor outcomes and promotes G1/S cell cycle progression in neuroblastoma
    Yaoyao Gu, Xiaoxiao Hu, Xiaowei Liu, Cheng Cheng, Kai Chen, Yeming Wu, Zhixiang Wu · 2021 · BMC Cancer
53. Magnesium in Combinatorial With Valproic Acid Suppressed the Proliferation and Migration of Human Bladder Cancer Cells
    Tianye Li, Yang Yu, Hang Shi, Yuhua Cao, Xiangfu Liu, Zhenzhen Hao, Yuping Ren, Gaowu W. Qin, Yongye Huang, Bing Wang · 2020 · Frontiers in Oncology
54. Bioinformatic Analysis of the Nicotinamide Binding Site in Poly(ADP-Ribose) Polymerase Family Proteins
    Garri Manasaryan, Dmitry A. Suplatov, Sergey V. Pushkarev, Viktor Drobot, Alexander N. Kuimov, Vytas K. Švedas, Dmitry K. Nilov · 2021 · Cancers
55. Integrin-α9β1 as a Novel Therapeutic Target for Refractory Diseases: Recent Progress and Insights
    Shihan Xu, Tingwei Zhang, Zhengguo Cao, Wenjie Zhong, Chuangwei Zhang, Han Li, Jinlin Song · 2021 · Frontiers in Immunology
56. Circulating EVs long RNA-based subtyping and deconvolution enable prediction of immunogenic signatures and clinical outcome for PDAC
    Yuchen Li, Ye Li, Shulin Yu, Ling Mei Qian, Kun Chen, Hongyan Lai, Hena Zhang, Yan Li, Yalei Zhang, Sijia Gu et al. · 2021 · Molecular Therapy — Nucleic Acids
57. CRISPR interference and activation of the microRNA-3662-HBP1 axis control progression of triple-negative breast cancer
    Baozhu Yi, Shuaibin Wang, Xinran Wang, Zhichao Liu, Chao Zhang, Ming Li, Song Gao, Shi Wei, Sejong Bae, Erica Michelle Stringer-Reasor et al. · 2021 · Oncogene
58. Anti-cancer therapeutic strategies based on HGF/MET, EpCAM, and tumor-stromal cross talk
    Khadijeh Barzaman, Rana Vafaei, Mitra Samadi, Mohammad Hossein Kazemi, Aysooda Hosseinzadeh, Parnaz Merikhian, Shima Moradi‐Kalbolandi, Mohammad Reza Eisavand, Houra Dinvari, Leila Farahmand · 2022 · Cancer Cell International
59. Current and novel approaches in the pharmacological treatment of hepatocellular carcinoma
    Fernanda Villarruel-Melquiades, María Eugenia Mendoza‐Garrido, Claudia María García-Cuellar, Yesennia Sánchez-Pérez, Julio Isael Pérez‐Carreón, Javier Camacho · 2023 · World Journal of Gastroenterology
60. Unmasking the Deceptive Nature of Cancer Stem Cells: The Role of CD133 in Revealing Their Secrets
    Julia Pospieszna, Hanna Dams‐Kozlowska, Wachirawit Udomsak, Marek Murias, Małgorzata Kucińska · 2023 · International Journal of Molecular Sciences
61. Hijacking homeostasis: Regulation of the tumor microenvironment by apoptosis
    Christopher D. Gregory · 2023 · Immunological Reviews
62. Diallyl trisulfide inhibits proliferation, invasion and angiogenesis of glioma cells by inactivating Wnt/β-catenin signaling
    Qingxia Tao, Cuiying Wu, Ruxiang Xu, Lijun Niu, Jiazhen Qin, Ning Liu, Peng Zhang, Chong Wang · 2017 · Cell and Tissue Research
63. Consistent LEF-1 and MYB Immunohistochemical Expression in Human Papillomavirus-Related Multiphenotypic Sinonasal Carcinoma: A Potential Diagnostic Pitfall
    Akeesha A. Shah, Bahram Robert Oliai, Justin A. Bishop · 2018 · Head and Neck Pathology
64. Integrative pathway-based survival prediction utilizing the interaction between gene expression and DNA methylation in breast cancer
    So Yeon Kim, Tae Rim Kim, Hyun-Hwan Jeong, Kyung-Ah Sohn · 2018 · BMC Medical Genomics
65. The strong propensity of Cadherin‐23 for aggregation inhibits cell migration
    Malay Kumar Sannigrahi, Cheerneni S. Srinivas, Nilesh Deokate, Sabyasachi Rakshit · 2019 · Molecular Oncology
66. Functional and transcriptomic characterization of carboplatin-resistant A2780 ovarian cancer cell line
    Támara Viscarra, Kurt Buchegger, Ignacio Jofré, Ismael Riquelme, Louise Zanella, Michel Abanto, Alyssa Parker, Stephen Piccolo, Juan Carlos Roa, Carmen Ili et al. · 2019 · Biological Research
67. Nanoparticles for Manipulation of the Developmental Wnt, Hedgehog, and Notch Signaling Pathways in Cancer
    Danielle M. Valcourt, Megan N. Dang, Jiaming Wang, Emily S. Day · 2019 · Annals of Biomedical Engineering
68. TRIM31 promotes acute myeloid leukemia progression and sensitivity to daunorubicin through the Wnt/β-catenin signaling
    Yi Xiao, Taoran Deng, Ming Xi, Jinhuang Xu · 2020 · Bioscience Reports
69. Steroid‐dependent switch of OvoL/Shavenbaby controls self‐renewal versus differentiation of intestinal stem cells
    Sandy Al Hayek, Ahmad Alsawadi, Zakaria Kambris, Jean‐Philippe Boquete, Jerome G. Bohere, Clément Immarigeon, Brice Ronsin, Serge Plaza, Bruno Lemaître, François Payre et al. · 2020 · The EMBO Journal
70. Combinatorial treatment with statins and niclosamide prevents CRC dissemination by unhinging the MACC1-β-catenin-S100A4 axis of metastasis
    Kortüm, Benedikt, Radhakrishnan, Harikrishnan, Zincke, Fabian, Sachse, Christoph, Burock, Susen, Keilholz, Ulrich, Dahlmann, Mathias, Walther, Wolfgang, Dittmar, Gunnar, Kobelt, Dennis et al. · 2022 · Oncogene
71. Current molecular understanding of central nervous system schwannomas
    Takahiro Tsuchiya, Satoru Miyawaki, Yu Teranishi, Kenta Ohara, Yudai Hirano, Shotaro Ogawa, Seiei Torazawa, Yu Sakai, Hiroki Hongo, Hideaki Ono et al. · 2025 · Acta Neuropathologica Communications
72. Frizzled receptors: gatekeepers of Wnt signaling in development and disease
    Dalia Martinez‐Marin, Grace C. Stroman, Camryn J. Fulton, Kevin Pruitt · 2025 · Frontiers in Cell and Developmental Biology
73. microRNA‐383 regulates cell viability and apoptosis by mediating Wnt/β‐catenin signaling pathway in non–small cell lung cancer
    Biao Gu, Jipeng Wang, Yaqi Song, Qi Wang, Qingquan Wu · 2018 · Journal of Cellular Biochemistry
74. The Canonical Wnt Signaling (Wnt/β-Catenin Pathway): A Potential Target for Cancer Prevention and Therapy
    S. Mahmoud A. Najafi · 2020 · Iranian Biomedical Journal
75. CBP-mediated Wnt3a/β-catenin signaling promotes cervical oncogenesis initiated by Piwil2
    Dingqing Feng, Keqin Yan, Haiyan Liang, Jing Liang, Wenhui Wang, Huan Yu, Ying Yin Zhou, Weidong Zhao, Zhongjun Dong, Bin Ling · 2020 · Neoplasia
76. LGR5 induces β‐catenin activation and augments tumour progression by activating STAT3 in human intrahepatic cholangiocarcinoma
    Keishi Kawasaki, Satoshi Kuboki, Katsunori Furukawa, Tsukasa Takayashiki, Shigetsugu Takano, Masayuki Ohtsuka · 2020 · Liver International
77. β-catenin in adrenal zonation and disease
    Donald W. Little, Typhanie Dumontet, Christopher Ryan LaPensee, Gary Douglas Hammer · 2020 · Molecular and Cellular Endocrinology
78. PLEKHA4 Promotes Wnt/β-Catenin Signaling–Mediated G1–S Transition and Proliferation in Melanoma
    Adnan Shami Shah, Xiaofu Cao, Andrew C. White, Jeremy M. Baskin · 2021 · Cancer Research
79. Metformin Dysregulates the Unfolded Protein Response and the WNT/β-Catenin Pathway in Endometrial Cancer Cells through an AMPK-Independent Mechanism
    Domenico Conza, Paola Mirra, Gaetano Calı̀, Luigi Insabato, Francesca Fiory, Francesco Bèguinot, Luca Ulianich · 2021 · Cells
80. A Warburg-like metabolic program coordinates Wnt, AMPK, and mTOR signaling pathways in epileptogenesis
    Roaya S. Alqurashi, Audrey S. Yee, Taylor Joseph Malone, Sumaiah D. Alrubiaan, Mary W. Tam, Kai Wang, Rozena R. Nandedwalla, Wesley Field, Dalal Ahmed Alkhelb, Katherine S. Given et al. · 2021 · PLoS ONE
81. Molecular mechanism, regulation, and therapeutic targeting of the STAT3 signaling pathway in esophageal cancer (Review)
    Ruijie Ma, Chao Ma, Kang Hu, Mengmeng Zhao, Nan Zhang, Zhigang Sun · 2022 · International Journal of Oncology
82. Tankyrase-Selective Inhibitor Stp1002 Shows Preclinical Antitumor Efficacy Without On-Target Toxicity in the Gastrointestinal Tract
    Dong Young Kim, Young-Ju Kwon, Won Yong Seo, Uk-Il Kim, Seohyun Ahn, Seong Mi Choi, Hyung Tae Bang, Kyung‐Jin Kim, Jae‐Sung Kim · 2022 · European Journal of Cancer
83. The metabolic addiction of cancer stem cells
    Om Saswat Sahoo, Karthikeyan Pethusamy, Tryambak Pratap Srivastava, Joyeeta Talukdar, Mohammed Saeed Alqahtani, Mohamed Abd Elhamid Abbas, Ruby Dhar, Subhradip Karmakar · 2022 · Frontiers in Oncology
84. Norbornene and Related Structures as Scaffolds in the Search for New Cancer Treatments
    Gorka Calvo-Martín, Daniel Plano, Nuria Martínez‐Sáez, Carlos Aydillo, Esther Moreno, Socorro Espuelas, Carmen Sanmartín · 2022 · Pharmaceuticals
85. The role of Evi/Wntless in exporting Wnt proteins
    Lucie Wolf, Michael Boutros · 2023 · Development
86. DKK1 is a predictive biomarker for response to DKN-01: Results of a phase 2 basket study in women with recurrent endometrial carcinoma
    Rebecca Christian Arend, Jhalak Dholakia, Cesar Castro, Ursula A. Matulonis, Erika Paige Hamilton, Camille Gunderson Jackson, Kristopher Lybarger, Howard M. Goodman, Linda Duska, Haider Mahdi et al. · 2023 · Gynecologic Oncology
87. Circular RNAs as the pivotal regulators of epithelial-mesenchymal transition in gastrointestinal tumor cells
    Reihaneh Alsadat Mahmoudian, Iman Akhlaghipour, Malihe Lotfi, Soodabeh Shahidsales, Meysam Moghbeli · 2023 · Pathology - Research and Practice
88. Targeting of oncogenic AAA-ATPase TRIP13 reduces progression of pancreatic ductal adenocarcinoma
    Farrukh Afaq, Sumit Agarwal, Prachi Bajpai, Sameer Al Diffalha, Hyung‐Gyoon Kim, Shajan Peter, Moh'd M. Khushman, Subhash C. Chauhan, Priyabrata Mukherjee, Sooryanarayana Varambally et al. · 2023 · Neoplasia
89. Signaling and molecular pathways implicated in oral cancer: A concise review
    Monika Kumari, Bhupender S. Chhikara, Priyamvada Singh, Brijesh Rathi, Geeta Singh · 2023 · Chemical Biology Letters
90. Ubiquitin Ligases Involved in the Regulation of Wnt, TGF-β, and Notch Signaling Pathways and Their Roles in Mouse Development and Homeostasis
    Nikol Dibus, Tomáš Liďák, Lukáš C̆ermák · 2019 · Genes
91. Depletion of H3K79 methyltransferase Dot1L promotes cell invasion and cancer stem-like cell property in ovarian cancer.
    Xian Wang, Hua Wang, Bo Xu, Dongrui Jiang, Shan Hong Huang, Hongzhen Yu, Zhengsheng Wu, Qiang Wu · 2019 · Europe PMC (PubMed Central)
92. Oncogenic dependency on β-catenin in liver cancer cell lines correlates with pathway activation
    Zhihu Ding, Chaomei Shi, Lan Jiang, Tatiana Tolstykh, Hui Cao, Dinesh S. Bangari, Susan Ryan, Mikhail N. Levit, Taiguang Jimmy Jin, Karl Mamaat et al. · 2017 · Oncotarget
93. Integration of Adverse Outcome Pathways, Causal Networks and ‘Omics to Support Chemical Hazard Assessment
    Edward J. Perkins, Alice Woolard, Natàlia García‐Reyero · 2022 · Frontiers in Toxicology
94. Gene Editing in Non-Small Cell Lung Cancer: Current Application and Future Perspective
    Hangxing Wang, Jingyun Fang, Yujiao Wang, Shuo Li, Zirui Wang, Wei He, Nan Wang, Shuang Luo, Huimei Zou, Fan Zhang · 2022 · ONCOLOGIE
95. Inhibiting WNT secretion reduces high bone mass caused by Sost loss-of-function or gain-of-function mutations in Lrp5
    Cassandra R. Diegel, Ina Krämer, Charles Moes, Gabrielle E. Foxa, Mitchell J. McDonald, Zachary Madaj, Sabine Guth, Jun Liu, Jennifer L. Harris, Michaela Kneissel et al. · 2023 · Bone Research
96. Cancer Stem Cells in Oral Squamous Cell Carcinoma: A Narrative Review on Experimental Characteristics and Methodological Challenges
    Surendra Kumar Acharya, Saptarsi Shai, Yee Fan Choon, Indrayadi Gunardi, Firstine Kelsi Hartanto, Kathreena Kadir, Ajoy Roychoudhury, Rahmi Amtha, Vui King Vincent–Chong · 2024 · Biomedicines
97. Perturbing LSD1 and WNT rewires transcription to synergistically induce AML differentiation
    Amir Hosseini, Abhinav Dhall, Nemo Ikonen, Natalia Sikora, Sylvain Nguyen, Yuqi Shen, Maria Luisa Jurgensen Amaral, Alan L. Jiao, Felice Wallner, Philipp Sergeev et al. · 2025 · Nature
98. CDK1‐mediated BCL9 phosphorylation inhibits clathrin to promote mitotic Wnt signalling
    Jianxiang Chen, Muthukumar Rajasekaran, Hongping Xia, Shik Nie Kong, Amudha Deivasigamani, Karthik Sekar, Hengjun Gao, Hannah L. F. Swa, Jayantha Gunaratne, London Lucien Ooi et al. · 2018 · The EMBO Journal
99. Retracted: MiR‐191‐5p inhibits lung adenocarcinoma by repressing SATB1 to inhibit Wnt pathway
    Lai‐yong Zhou, Fu‐wei Zhang, Jian Tong, Fang Liu · 2019 · Molecular Genetics & Genomic Medicine · Retracted
100. CDDO-Me Elicits Anti-Breast Cancer Activity by Targeting LRP6 and FZD7 Receptor Complex
     Liang Zhou, Zhongyuan Wang, Shubin Yu, Yanpeng Xiong, Jiaoyang Fan, Yansi Lyu, Zijie Su, Jiaxing Song, Shanshan Liu, Qi Sun et al. · 2019 · Journal of Pharmacology and Experimental Therapeutics